fashion -WSS

fashion

author：explore 2025-10-01 17:21:10 - browse：14249

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for cancer patients if it means making more money.

Genentech CEO Alexander Hardy, in an interview with STAT, explained that in the world that existed prior to the Inflation Reduction Act’s passage last year, drugmakers were incentivized to get drugs on the market as fast as possible, regardless of which disease they would be approved to treat.

Now, he’s arguing that the law’s new Medicare negotiation program could encourage Genentech to slow-walk research on how a drug could treat diseases with smaller populations in favor of making sure diseases with larger patient populations are the first to market. That would mean the company would sell more medicines in the window before Medicare is allowed to negotiate prices, because the clock for when discounts can kick in is based off of when the drug first goes on the market.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Elevance, private equity launch primary care company

Wikipedia

focus

hotspot

WSS

FDA clears Verve to begin U.S. study of gene

First recipient of genetically engineered pig kidney has died

H5N1 bird flu: what we're starting to learn about infection in cows

Roche drug slashes death risk in early

Dairy farmers resist CDC push for PPE against bird flu virus

Sanofi strikes deal with Novavax, boosting the vaccine maker

entertainment

fashion

entertainment

Novavax promises a turnaround & Lilly roils the obesity market

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: Live from the 2023 STAT Summit

Activists slam private health insurers over coverage restrictions

CZI to create biohub to build anti

How to save PrEP access — and even expand it

Google says AlphaFold 3 can map a vast universe of biomolecules

Affirmative action in medical school literally saved lives

CDC wastewater surveillance dashboard to track bird flu hotspots

focus

UnitedHealth, Optum discontinue NaviHealth name

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

Medicare says breakthrough device reimbursement rule to come by summer

How AI can help patients find reliable information about doctors

STAT Summit: Doctor v. ChatGPT showed AI's promise, blind spots

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Wikipedia

focus

hotspot

hotspot